ReviewMolecular informatics2026
Transformer Learning in Sequence-Based Drug Design Depends on Compound Memorization and Similarity of Sequence-Compound Pairs.
Review in Molecular informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- 3DICE: interpretable 3D cross-modal learning for drug-target interaction prediction and large-scale drug discovery.Bioinformatics (Oxford, England) · 2026Article
- Transformer Learning in Sequence-Based Drug Design Depends on Compound Memorization and Similarity of Sequence-Compound Pairs.Molecular informatics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemical language models (CLMs), particularly encoder-decoder transformers, have advanced generative molecular design. Transformer CLMs are able to learn a variety of molecular mappings for compound design that can be conditioned using context-dependent rules. However, their black-box nature complicates the interpretation of predictions. Current analysis methods mostly focus on attention weights of token relationships or attention flow in encoder and decoder modules and cannot explain predictions at the molecular level. Sequence-based compound design was used as a model system to investigate transformer learning characteristics through systematic control calculations involving modifications of protein sequences and sequence-compound pairs. The analysis revealed that compound reproducibility depended on similarity relationships between training and test data and on compound memorization, while specific sequence information was not learned. These findings indicate that predictions of transformer CLMs are driven by memorization effects and statistical correlations rather than by learning specific chemical or biological information. Understanding this learning behavior aids in avoiding over-interpretation of model outputs and informs the appropriate application of transformer-based CLMs in molecular design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.